Janney Montgomery Scott
SUPN icon

Janney Montgomery Scott’s Supernus Pharmaceuticals SUPN Stock Holding History

Janney Montgomery Scott’s Portfolio SUPN Stock Details SUPN Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2025
Q1 		– Sell
-5,849
Closed -$211K – 2860
2024
Q4 		$211K Buy
+5,849
New +$206K ﹤0.01% 2526
2023
Q2 		– Sell
-5,686
Closed -$206K – 2733
2023
Q1 		$206K Sell
5,686
-70
-1% -$2.69K ﹤0.01% 2272
2022
Q4 		$205K Buy
+5,756
New +$200K ﹤0.01% 2364
2021
Q3 		– Sell
-9,169
Closed -$282K – 2372
2021
Q2 		$282K Sell
9,169
-215
-2% -$6.59K ﹤0.01% 1944
2021
Q1 		$246K Buy
+9,384
New +$262K ﹤0.01% 1963
2018
Q4 		– Sell
-13,860
Closed -$698K – 2047
2018
Q3 		$698K Buy
13,860
+3,039
+28% +$150K 0.01% 1265
2018
Q2 		$648K Buy
+10,821
New +$561K 0.01% 1246

Other funds holding SUPN

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
AC
Armistice Capital New York $5.62B AUM 36.06% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Macquarie Group
Macquarie Group Sydney, NSW 2000, Australia $16.8B AUM 27.39% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
SIMG
Stephens Investment Management Group Houston, Texas $7.3B AUM 41.96% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Loomis, Sayles & Company
Loomis, Sayles & Company Boston, Massachusetts $74.3B AUM 24.01% 1-Year Est. Return
GKIM
GW&K Investment Management Boston, Massachusetts $11.3B AUM 31.98% 1-Year Est. Return

Janney Montgomery Scott's SUPN Position: Q1 2025 in Review

Janney Montgomery Scott sold out of Supernus Pharmaceuticals (SUPN) in Q1 2025, closing a stake of 5,849 shares — an estimated $211K sold.

Janney Montgomery Scott first reported a position in SUPN in Q2 2018 and held it in 7 quarters. The position peaked at $698K in Q3 2018. 295 funds tracked by Wall St. Rank hold SUPN as of Q1 2025.

  • Janney Montgomery Scott reported no remaining Supernus Pharmaceuticals position as of Q1 2025 after selling out during the quarter.
  • Janney Montgomery Scott sold 5,849 Supernus Pharmaceuticals shares in Q1 2025, an estimated $211K.
  • Janney Montgomery Scott first reported a position in Supernus Pharmaceuticals in Q2 2018 and held it in 7 quarters.
  • Janney Montgomery Scott's Supernus Pharmaceuticals position peaked at $698K in Q3 2018.
  • 295 funds tracked by Wall St. Rank held Supernus Pharmaceuticals as of Q1 2025.

Based on Janney Montgomery Scott's 13F filing for Q1 2025, filed 17 Apr 2025.